Top Stories
-
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
-
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
-
Barring ovarian cancer surgery at low-volume hospitals could limit access to care for many rural and underserved patients, a new study has found.
Topic
-
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.
Topic
Latest News
- November 16, 2017
Discoveries made by researchers at HICCC have fundamentally altered our understanding of cancer.
- October 11, 2017
Columbia researchers have identified cells that give rise to Barrett’s esophagus, a precursor to esophageal cancer, the fastest-growing cancer in the United States.
Topic
- October 9, 2017
Riders, sponsors, volunteers, and friends joined forces for Velocity, Columbia's Ride to End Cancer, in support of the Herbert Irving Comprehensive Cancer Center.
Topic
- September 7, 2017
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Topic
- August 30, 2017
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.
Topic
- August 30, 2017
Prakash Satwani, MD, leads NYP/CUMC's program in CAR-T therapy, a new treatment that uses a patient's own T cells to attack cancer.
Topic
- July 11, 2017
Inna Kleyman, MD, shares why she joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
- July 11, 2017
Ilene Anesini shares why she joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
- July 11, 2017
Alexander Small, MD, shares why he joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
- July 10, 2017
Velocity is a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC. Columbia riders share why they joined the cause.
Topic
